Average obligated amount per year since period start.
Portion of total contract value already obligated.
Share of total value represented by subawards.
CUTTING EDGE TECHNOLOGIES WILL BE USED TO BOTH DISCOVER AND CHARACTERIZE HUMAN B CELL EPITOPES ON BACTERIAL SURFACE ANTIGENS KNOWN TO BE INVOLVED IN IMMUNITY TO B. BURGDORERI INFECTION.
Task order obligations
Estimated months remaining until end of performance.
Period of performance
34% of period elapsed
Awarding Agency
NINATIONAL INSTITUTES OF HEALTH
Code: 7529
Funding Agency
NINATIONAL INSTITUTES OF HEALTH
Code: 7529
Loading contract activity data...
Modification ID | Description | Action Date | Obligated Amount | Action Type |
|---|---|---|---|---|
Subaward # | Subawardee | Description | Amount | Action Date |
|---|---|---|---|---|